Frontiers in Immunology | Alloimmunity and Transplantation

Case Report

Published on 17 Jan 2025

Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report

in Alloimmunity and Transplantation

Jiaying Zhang
Yuan Gao
Xiaoyun Miao
Wei Wang
Zhongkai Zhou
Yunyi Gao
Liwei Liu
Menghua Wu
Ke Ma
Ling Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501813

217 views

Clinical Trial

Published on 17 Jan 2025

Assessing donor kidney function: the role of CIRBP in predicting delayed graft function post-transplant

in Alloimmunity and Transplantation

Qianghua Leng
Maolin Ma
Zuofu Tang
Weichen Jiang
Fei Han
Zhengyu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518279

113 views

Original Research

Published on 16 Jan 2025

Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA

in Alloimmunity and Transplantation

Yuan Tian
Lukas Frischknecht
Anna Mallone
Fabian Rössler
Thomas Schachtner
Jakob Nilsson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1530065

433 views

Review

Published on 15 Jan 2025

Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context

in Alloimmunity and Transplantation

Valentine Wang
Barbara Savoldo
José-Arthur Guimaraes
Gianpietro Dotti
Loïc Reppel
Danièle Bensoussan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527648

184 views

Review

Accepted on 13 Jan 2025

Advances in Allogeneic Hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children

in Alloimmunity and Transplantation

Guangqiang Meng
Saran Feng
Yan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1345855

Original Research

Accepted on 13 Jan 2025

Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients

in Alloimmunity and Transplantation

Gökce Yavuz
Julia Walter
Kaimo Hirv
Oliver Wachter
Andrea Dick
Julia Kovács
Julia Zimmermann
Olaf Michael Glueck
Maximilian Vorstandlechner
Nicole Samm

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531774

Original Research

Published on 09 Jan 2025

ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IκBα/cRel pathway

in Alloimmunity and Transplantation

Xiaofei Huang
Yuqun Zeng
Jingru Lin
Huazhen Liu
Chun-Ling Liang
Yuchao Chen
Feifei Qiu
Jonathan S. Bromberg
Zhenhua Dai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1529226

110 views

Original Research

Published on 08 Jan 2025

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia

in Alloimmunity and Transplantation

Mingyang Wang
Shulian Chen
Qiuqiu Zhang
Linyu Yuan
Xue Wang
Junshi Zhang
Xiaoyu Zhang
Yigeng Cao
Dongmei Li
Xinxiao Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1511057

273 views

Brief Research Report

Accepted on 07 Jan 2025

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database

in Alloimmunity and Transplantation

Alexandre O. Gérard
Diane Merino
Jonathan Benzaquen
Alexandre Destere
Delphine Borchiellini
Clément Gosset
Fanny Rocher
Marine Andreani
Charles-Hugo Marquette
Henri Montaudié

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514033

Mini Review

Accepted on 07 Jan 2025

Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy

in Alloimmunity and Transplantation

Yanjiao Li
Jinyu Zhu
Congyang Yue
Si-Yuan Song
Yi Wang
Limin Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551372

Review

Published on 07 Jan 2025

Targeting the chemokines in acute graft-versus-host disease

in Alloimmunity and Transplantation

Ziwei Xu
Huafang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1525244

174 views

Review

Published on 07 Jan 2025

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria

in Alloimmunity and Transplantation

Marek Ussowicz
Dawid Przystupski
Patrycja Mensah-Glanowska
Agnieszka Piekarska

Frontiers in Immunology

doi 10.3389/fimmu.2024.1521484

188 views

Original Research

Published on 07 Jan 2025

Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care

in Alloimmunity and Transplantation

María Queralt Salas
María Teresa Solano
Mónica Baile González
Marina Acera Gómez
Laura Fox
María del Mar Pérez Artigas
Ana Santamaría
María del Carmen Quintela González
Andrés Sánchez Salinas
Joaquina M. Salmerón Camacho

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512154

189 views

Original Research

Published on 07 Jan 2025

Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomes

in Alloimmunity and Transplantation

Christoph F. Mahler
Felix Friedl
Christian Nusshag
Claudius Speer
Louise Benning
Daniel Göth
Matthias Schaier
Claudia Sommerer
Markus Mieth
Arianeb Mehrabi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1511368

168 views

Review

Published on 07 Jan 2025

Transplant oncology and anti-cancer immunosuppressants

in Alloimmunity and Transplantation

Dejun Kong
Jinliang Duan
Shaofeng Chen
Zhenglu Wang
Jiashu Ren
Jianing Lu
Tao Chen
Zhuolun Song
Di Wu
Yuan Chang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1520083

339 views

Original Research

Accepted on 06 Jan 2025

Beta2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model

in Alloimmunity and Transplantation

Paolo Durigutto
Maria Cristina Grimaldi
Sara Bozzer
Elena Raschi
Pier Luigi Meroni
Francesco Tedesco
Paolo Macor

Frontiers in Immunology

doi 10.3389/fimmu.2025.1520619

Navigation group

Articles

Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report

Assessing donor kidney function: the role of CIRBP in predicting delayed graft function post-transplant

Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA

Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context

Advances in Allogeneic Hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children

Donor-derived cell-free DNA for detection of acute rejection in lung transplant recipients

ESAT-6 protein suppresses allograft rejection by inducing CD4+Foxp3+ regulatory T cells through IκBα/cRel pathway

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia

PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance database

Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy

Targeting the chemokines in acute graft-versus-host disease

Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria

Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care

Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomes

Transplant oncology and anti-cancer immunosuppressants

Beta2GPI-targeted polymeric nanoparticles form a protective layer to prevent vascular thrombosis in an anti-phospholipid syndrome model